Protective effectiveness of inactivated hantavirus vaccine against hemorrhagic fever with renal syndrome

Jaehun Jung, Sung Jun Ko, Hong Sang Oh, Song Mi Moon, Jin Won Song, Kyungmin Huh

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

As there is no effective treatment against hemorrhagic fever with renal syndrome (HFRS), the development of effective vaccine is important. An inactivated hantavirus vaccine (IHV) has been used in Korea, but there has been controversy regarding its effectiveness. We conducted a case-control study to evaluate the vaccine effectiveness (VE) of IHV against HFRS in the Korean military. Unadjusted and adjusted VEs of IHV were 59.1% and 58.9%, respectively. VE was higher in divisions with high incidence of HFRS (unadjusted VE, 71.4%; adjusted VE, 78.7%). Our study demonstrated the moderate effectiveness of IHV in high-risk populations residing in endemic area.

Original languageEnglish
Pages (from-to)1417-1420
Number of pages4
JournalJournal of Infectious Diseases
Volume217
Issue number9
DOIs
Publication statusPublished - 2018 May 1

Fingerprint

Hantavirus
Hemorrhagic Fever with Renal Syndrome
Inactivated Vaccines
Vaccines
Korea
Case-Control Studies
Incidence
Population

Keywords

  • Hantavirus
  • Hemorrhagic fever with renal syndrome
  • Vaccine

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Protective effectiveness of inactivated hantavirus vaccine against hemorrhagic fever with renal syndrome. / Jung, Jaehun; Ko, Sung Jun; Oh, Hong Sang; Moon, Song Mi; Song, Jin Won; Huh, Kyungmin.

In: Journal of Infectious Diseases, Vol. 217, No. 9, 01.05.2018, p. 1417-1420.

Research output: Contribution to journalArticle

Jung, Jaehun ; Ko, Sung Jun ; Oh, Hong Sang ; Moon, Song Mi ; Song, Jin Won ; Huh, Kyungmin. / Protective effectiveness of inactivated hantavirus vaccine against hemorrhagic fever with renal syndrome. In: Journal of Infectious Diseases. 2018 ; Vol. 217, No. 9. pp. 1417-1420.
@article{0272dff0163f4ff185955db0181cea2b,
title = "Protective effectiveness of inactivated hantavirus vaccine against hemorrhagic fever with renal syndrome",
abstract = "As there is no effective treatment against hemorrhagic fever with renal syndrome (HFRS), the development of effective vaccine is important. An inactivated hantavirus vaccine (IHV) has been used in Korea, but there has been controversy regarding its effectiveness. We conducted a case-control study to evaluate the vaccine effectiveness (VE) of IHV against HFRS in the Korean military. Unadjusted and adjusted VEs of IHV were 59.1{\%} and 58.9{\%}, respectively. VE was higher in divisions with high incidence of HFRS (unadjusted VE, 71.4{\%}; adjusted VE, 78.7{\%}). Our study demonstrated the moderate effectiveness of IHV in high-risk populations residing in endemic area.",
keywords = "Hantavirus, Hemorrhagic fever with renal syndrome, Vaccine",
author = "Jaehun Jung and Ko, {Sung Jun} and Oh, {Hong Sang} and Moon, {Song Mi} and Song, {Jin Won} and Kyungmin Huh",
year = "2018",
month = "5",
day = "1",
doi = "10.1093/infdis/jiy037",
language = "English",
volume = "217",
pages = "1417--1420",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Protective effectiveness of inactivated hantavirus vaccine against hemorrhagic fever with renal syndrome

AU - Jung, Jaehun

AU - Ko, Sung Jun

AU - Oh, Hong Sang

AU - Moon, Song Mi

AU - Song, Jin Won

AU - Huh, Kyungmin

PY - 2018/5/1

Y1 - 2018/5/1

N2 - As there is no effective treatment against hemorrhagic fever with renal syndrome (HFRS), the development of effective vaccine is important. An inactivated hantavirus vaccine (IHV) has been used in Korea, but there has been controversy regarding its effectiveness. We conducted a case-control study to evaluate the vaccine effectiveness (VE) of IHV against HFRS in the Korean military. Unadjusted and adjusted VEs of IHV were 59.1% and 58.9%, respectively. VE was higher in divisions with high incidence of HFRS (unadjusted VE, 71.4%; adjusted VE, 78.7%). Our study demonstrated the moderate effectiveness of IHV in high-risk populations residing in endemic area.

AB - As there is no effective treatment against hemorrhagic fever with renal syndrome (HFRS), the development of effective vaccine is important. An inactivated hantavirus vaccine (IHV) has been used in Korea, but there has been controversy regarding its effectiveness. We conducted a case-control study to evaluate the vaccine effectiveness (VE) of IHV against HFRS in the Korean military. Unadjusted and adjusted VEs of IHV were 59.1% and 58.9%, respectively. VE was higher in divisions with high incidence of HFRS (unadjusted VE, 71.4%; adjusted VE, 78.7%). Our study demonstrated the moderate effectiveness of IHV in high-risk populations residing in endemic area.

KW - Hantavirus

KW - Hemorrhagic fever with renal syndrome

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=85050749672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050749672&partnerID=8YFLogxK

U2 - 10.1093/infdis/jiy037

DO - 10.1093/infdis/jiy037

M3 - Article

C2 - 29373686

AN - SCOPUS:85050749672

VL - 217

SP - 1417

EP - 1420

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 9

ER -